Literature DB >> 19331153

Survivin may enhance DNA double-strand break repair capability by up-regulating Ku70 in human KB cells.

Gaofeng Jiang1, Bo Ren, Lei Xu, Shizhen Song, Changcai Zhu, Fangli Ye.   

Abstract

BACKGROUND: Survivin, expressed in almost all types of human malignancies, functions as a key factor in radioresistance primarily by inhibiting apoptosis. This study was conducted to investigate whether survivin plays a role in the DNA repair process in the KB human squamous cell carcinoma cell line.
MATERIALS AND METHODS: A stable KB cell line overexpressing survivin was established through the use of pIRES2-EGFP vector containing the coding region of survivin. Cells were then irradiated with X-rays and evaluated for DNA double-strand breaks (DSBs) by comet assay and flow cytometry for phospho-histone gammaH2AX. The protein levels of some DSB repair genes were detected by Western blotting analysis.
RESULTS: Comet assay and flow cytometry for phospho-histone gammaH2AX showed that overexpression of survivin resulted in significantly fewer DSBs in irradiated cells. Among the DSB repair genes detected, the protein level of Ku70 was up-regulated in survivin-overexpressing KB cells.
CONCLUSION: This finding suggests that survivin may enhance DSB repair capability in KB cells by up-regulating Ku70.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19331153

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  14 in total

1.  The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin.

Authors:  Anjaiah Srirangam; Monica Milani; Ranjana Mitra; Zhijun Guo; Mariangellys Rodriguez; Hitesh Kathuria; Seiji Fukuda; Anthony Rizzardi; Stephen Schmechel; David G Skalnik; Louis M Pelus; David A Potter
Journal:  J Thorac Oncol       Date:  2011-04       Impact factor: 15.609

2.  Response prediction to oxaliplatin plus 5-fluorouracil chemotherapy in patients with colorectal cancer using a four-protein immunohistochemical model.

Authors:  Junjie Gu; Zhe Li; Jianfeng Zhou; Zhao Sun; Chunmei Bai
Journal:  Oncol Lett       Date:  2019-06-14       Impact factor: 2.967

3.  Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.

Authors:  Xu Wang; Jonathan J Beitler; Wen Huang; Guo Chen; Guoqing Qian; Kelly Magliocca; Mihir R Patel; Amy Y Chen; Jun Zhang; Sreenivas Nannapaneni; Sungjin Kim; Zhengjia Chen; Xingming Deng; Nabil F Saba; Zhuo Georgia Chen; Jack L Arbiser; Dong M Shin
Journal:  Clin Cancer Res       Date:  2017-11-27       Impact factor: 12.531

4.  Enhancement of 5-fluorouracil-induced in vitro and in vivo radiosensitization with MEK inhibition.

Authors:  Mary Ellen Urick; Eun Joo Chung; William P Shield; Naamit Gerber; Ayla White; Anastasia Sowers; Angela Thetford; Kevin Camphausen; James Mitchell; Deborah E Citrin
Journal:  Clin Cancer Res       Date:  2011-06-20       Impact factor: 12.531

5.  Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells.

Authors:  Chun Hei Antonio Cheung; Huang-Hui Chen; Li-Ting Cheng; Kevin W Lyu; Jagat R Kanwar; Jang-Yang Chang
Journal:  Mol Cancer       Date:  2010-04-15       Impact factor: 27.401

6.  Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs.

Authors:  T Iwasa; I Okamoto; K Takezawa; K Yamanaka; T Nakahara; A Kita; H Koutoku; M Sasamata; E Hatashita; Y Yamada; K Kuwata; M Fukuoka; K Nakagawa
Journal:  Br J Cancer       Date:  2010-06-01       Impact factor: 9.075

Review 7.  Monitoring survivin expression in cancer: implications for prognosis and therapy.

Authors:  Rodrigo Santa Cruz Guindalini; Maria Cecília Mathias Machado; Bernardo Garicochea
Journal:  Mol Diagn Ther       Date:  2013-12       Impact factor: 4.074

8.  Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer.

Authors:  Alessia Lopergolo; Michele Tavecchio; Sofia Lisanti; Jagadish C Ghosh; Takehiko Dohi; Alice Faversani; Valentina Vaira; Silvano Bosari; Nobuhiko Tanigawa; Domenico Delia; Andrew V Kossenkov; Louise C Showe; Dario C Altieri
Journal:  Cancer Res       Date:  2012-05-14       Impact factor: 12.701

9.  A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy.

Authors:  Chun Hei Antonio Cheung; Xueying Sun; Jagat R Kanwar; Ji-Zhong Bai; Liting Cheng; Geoffrey W Krissansen
Journal:  Cancer Cell Int       Date:  2010-10-01       Impact factor: 5.722

10.  CXCR4 expression in the bone marrow microenvironment is required for hematopoietic stem and progenitor cell maintenance and early hematopoietic regeneration after myeloablation.

Authors:  Pratibha Singh; Khalid S Mohammad; Louis M Pelus
Journal:  Stem Cells       Date:  2020-03-19       Impact factor: 5.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.